Cargando…
Engineered exosomes for targeted delivery of miR-187-3p suppress the viability of hemangioma stem cells by targeting Notch signaling
BACKGROUND: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy and is proposed to arise from hemangioma stem cells (HemSCs). Therapies for IH include oral beta-blockers, surgery, and the delivery of novel therapeutic agents, such as bioactive microRNAs (miRNAs). However, i...
Autores principales: | Zhao, Ze-Liang, Liu, Chao, Wang, Qi-Zhang, Wu, Hai-Wei, Zheng, Jia-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263766/ https://www.ncbi.nlm.nih.gov/pubmed/35813344 http://dx.doi.org/10.21037/atm-21-4138 |
Ejemplares similares
-
MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9
por: Liang, Zhihua, et al.
Publicado: (2019) -
miR-187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2017) -
miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma
por: Cui, Chengliang, et al.
Publicado: (2017) -
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2023) -
Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor
por: Lin, Shu-Chun, et al.
Publicado: (2016)